Key result
The hCaV3.3 R1346H variant cuts whole-cell current densities ~50% versus wild-type, eliminating rebound bursting.
Why the study?
CACNA1I is a candidate schizophrenia risk gene with de novo missense variants whose functional impact on CaV3.3 channel activity and neuronal function is unclear.
Does the R1346H variant of CACNA1I disrupt CaV3.3 channel activity compared to wild-type?
Does the R1346H variant of CACNA1I disrupt CaV3.3 channel activity compared to wild-type?
p-value: p=<0.0001
The R1346H variant of CACNA1I reduces CaV3.3 channel activity and may disrupt rebound bursting in TRN neurons, potentially contributing to schizophrenia pathophysiology.
R1346H may impair thalamic bursting in models; leaves open a causal role in schizophrenia pending human studies.
CACNA1I is a candidate schizophrenia risk gene. It encodes the pore-forming human CaV3.3 α1 subunit, a subtype of voltage-gated calcium channel that contributes to T-type currents. Recently, two de novo missense variations, T797M and R1346H, of hCaV3.3 were identified in individuals with schizophrenia. Here we show that R1346H, but not T797M, is associated with lower hCaV3.3 protein levels, reduced glycosylation, and lower membrane surface levels of hCaV3.3 when expressed in human cell lines compared to wild-type. Consistent with our biochemical analyses, whole-cell hCaV3.3 currents in cells expressing the R1346H variant were ~50% of those in cells expressing WT hCaV3.3, and neither R1346H nor T797M altered channel biophysical properties. Employing the NEURON simulation environment, we found that reducing hCaV3.3 current densities by 22% or more eliminates rebound bursting in model thalamic reticular nucleus (TRN) neurons. Our analyses suggest that a single copy of Chr22: 39665939G > A CACNA1I has the capacity to disrupt CaV3.3 channel-dependent functions, including rebound bursting in TRN neurons, with potential implications for schizophrenia pathophysiology.
No takes yet. Share an insight, caveat, or question.
Andrade et al. (2016) studied Schizophrenia (preclinical model). R1346H variant of hCaV3.3 vs. Wild-type hCaV3.3 was evaluated on Whole-cell hCaV3.3 current density (p=<0.0001). The R1346H variant of hCaV3.3 reduced whole-cell current densities by approximately 50% compared to wild-type, eliminating rebound bursting in model thalamic reticular nucleus neurons.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: